EliOwenMeltzerMD

PubMed

• Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials.
  Mullol, J., Ko, J., Saenz, R., Steinke, J., Millette, L., Gevaert, P., Meltzer, E.> ;International Forum of Allergy & Rhinology. 2024 Jan 10
• Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
  Philippe Gevaert, Joaquim Mullol, Rebecca Saenz, Jinnie Ko, John W Steinke, Lauren A Millette, Eli O Meltzer> ;Annals of Allergy, Asthma & Immunology. 2024 Mar 1
• Correction: Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis.
  Eli O Meltzer, Nelson Augusto Rosario, Hugo Van Bever, Luiz Lucio> ;Allergy, Asthma, and Clinical Immunology. 2022 Dec 27
• 1 citations
  Evaluation of the ocular safety associated with the exhalation delivery system with fluticasone.
  David P. Skoner, Eli O. Meltzer, Jonathan D. Skoner, H. Sacks, William R. Lumry> ;Allergy and Asthma Proceedings. 2021 Nov 9
• 7 citations
  Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis.
  Eli O Meltzer, Nelson Rosario, Hugo Van Bever, Luiz Lucio> ;Allergy, Asthma, and Clinical Immunology. 2021 Nov 2
• 5 citations
  Meta-analyses of the efficacy of pharmacotherapies and sublingual allergy immunotherapy tablets for allergic rhinitis in adults and children.
  E O Meltzer, D Wallace, H S Friedman, P Navaratnam, E P Scott, Hendrik Nolte> ;Rhinology. 2021 Aug 31
• 45 citations
  Prevalence and Burden of Chronic Cough in the United States
  Eli O. Meltzer, Robert S. Zeiger, Peter V. Dicpinigaitis, Jonathan A. Bernstein, John Oppenheimer, Nate A. Way, Vicky Li, Robert Boggs, Michael J. Doane, Eduardo Urdan...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 Jul 29
• 17 citations
  ARIA-EAACI Care Pathways for Allergen Immunotherapy in Respiratory Allergy
  Jean Bousquet, Oliver Pfaar, Ioana Agache, Anna Bedbrook, Cezmi A. Akdis, G. Walter Canonica, Tomas Chivato, Mona Al-Ahmad, Amir Hamzah Abdul Latiff, Ignacio J. Ansote...> ;Clinical and Translational Allergy. 2021 Jun 1
• 13 citations
  Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies.
  Tonya Winders, Lawrence M. DuBuske, Don A. Bukstein, Eli O. Meltzer, Dana Wallace, Karen Rance> ;Allergy and Asthma Proceedings. 2021 May 24
• 35 citations
  ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
  Jean Bousquet, Josep M. Antó, Claus Bachert, Tari Haahtela, Torsten Zuberbier, Wienczyslawa Czarlewski, Anna Bedbrook, Sinthia Bosnic-Anticevich, G. Walter Canonica, V...> ;Allergy. 2021 Jan 1
• 2 citations
  Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
  Eli O. Meltzer, Claus Bachert, Michael Mayer, Ferdinand Kopietz, Arkady Koltun, Joachim Maus, Alexander D. D'addio> ;Allergy and Asthma Proceedings. 2020 May 11
• 8 citations
  Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5.
  Roland Buhl, JM FitzGerald, Eli O. Meltzer, Alberto de la Hoz, Ralf Sigmund, Huib A. M. Kerstjens, Eugene R. Bleecker> ;Pulmonary Pharmacology & Therapeutics. 2020 Feb 1
• 11 citations
  Tiotropium Respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics
  Thomas B. Casale, René Aalbers, Eugene R. Bleecker, Eli O. Meltzer, Liliana Zaremba-Pechmann, Alberto de la Hoz, Huib A. M. Kerstjens> ;Respiratory Medicine. 2019 Oct 1
• 70 citations
  Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
  Jean Bousquet, Holger J. Schünemann, Alkis Togias, Marina Erhola, Peter Hellings, Torsten Zuberbier, Ioana Agache, Ignacio J. Ansotegui, Josep M. Antó, Claus Bachert, ...> ;Clinical and Translational Allergy. 2019 Sep 9
• 11 citations
  Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV 1
  David M.G. Halpin, Eli O. Meltzer, Wendelgard Pisternick-Ruf, Petra Moroni-Zentgraf, Michael Engel, Liliana Zaremba-Pechmann, Thomas B. Casale, J. Mark FitzGerald> ;Respiratory Research. 2019 Jul 18
• 51 citations
  Shared decision making for the allergist.
  Michael S. Blaiss, Gary C. Steven, Bruce G. Bender, Don A. Bukstein, Eli O. Meltzer, Tonya Winders> ;Annals of Allergy, Asthma & Immunology. 2019 May 1
• 80 citations
  Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
  Jean Bousquet, Peter Hellings, Ioana Agache, Flore Amat, Isabella Annesi-Maesano, Ignacio J. Ansotegui, Josep M. Antó, Claus Bachert, Eric D. Bateman, Anna Bedbrook, K...> ;The Journal of Allergy and Clinical Immunology. 2019 Mar 1
• 38 citations
  Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
  Jean Bousquet, Eli O. Meltzer, Peter Couroux, Arkady Koltun, Ferdinand Kopietz, Ullrich Munzel, Hans Christian Kuhl, Duc Tung Nguyen, Anne Marie Salapatek, David Price> ;The Journal of Allergy and Clinical Immunology. in Practice. 2018 Sep 1
• 1 citations
  A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
  Eli O Meltzer, William E Berger> ;Allergy and Asthma Proceedings. 2018 Jan 6
• 87 citations
  Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update.
  Mark S. Dykewicz, Dana Wallace, Fuad M. Baroody, Jonathan A. Bernstein, Timothy J. Craig, Ira Finegold, Faith Huang, Désirée Larenas-Linnemann, Eli O. Meltzer, Gary C....> ;Annals of Allergy, Asthma & Immunology. 2017 Dec 1
• A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
  E O Meltzer, W E Berger> ;Allergy and asthma proceedings. 2017 Nov 6
• 946 citations
  Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
  Jan Brozek, Jean Bousquet, Ioana Agache, Arnav Agarwal, Claus Bachert, Sinthia Bosnic-Anticevich, Romina Brignardello-Petersen, G. Walter Canonica, Thomas B. Casale, N...> ;The Journal of Allergy and Clinical Immunology. 2017 Oct 1
• 42 citations
  Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients
  Eli O. Meltzer, Judith R Farrar, Cary Sennett> ;The Journal of Allergy and Clinical Immunology. in Practice. 2017 May 1
• Hot Topics in Primary Care: Sublingual Immunotherapy: A Guide for Primary Care.
  Eli O. Meltzer> ;The Journal of Family Practice. 2017 Apr 1
• 7 citations
  Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Are...
  Jean Bousquet, John Farrell, G. Crooks, P Hellings, E.H.D. Bel, M. Bewick, Niels H. Chavannes, Jaime Correia de Sousa, Alfredo Arias Cruz, Tari Haahtela, Guy Joos, Nik...> ;Clinical and Translational Allergy. 2017 Feb 20
• Join now to see all

Journal Articles

• Safety and efficacy of the prostaglandin D2 receptor antagonist AMG853 in asthmatic patients  
  Busse WW, Wenzel SE, Meltzer EO, Kerwin EM, Liu MC, Zhang N, Chon Y, Budelsky AL, Lin J, Lin, S-L, J Allergy Clin Immunol, 1/1/2013
• Reliabilty, validity, and responsiveness of the Rhinits Control Assessment Test in patients with rhinitis  
  Meltzer EO, Schatz M, Nathan R, Garris C, Stanford RH, Kosinski M, J Allergy Clin Immunol, 1/1/2013
• Reliving nasal congestion in children with seasonal and perennial allergic rhinitis: efficacy and safety studies of mometaxone furoate nasal spray  
  Meltzer EO, Baena-Cagnani CE, Gates D, Teper A, World Allergy Organization Journal, 1/1/2013
• Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinits assessed by responder analysis  
  Meltzer E, Ratner P, Bachert C, Carr W, Berger W, Canonica GW, Hadley J, Lieberman P, Hampel FC, Mullol J, Munzel U, Price D, Scadding G, Virchow JC, Wahn U, Murray R,..., Int Arch Allergy Immunol, 1/1/2013
• An algorithm for the management of allergic conjunctivitis  
  Bielory L, Meltzer EO, Nichols KK, Melton R, Thomas RK, Bartlett JD, Allergy Asthma Proc, 1/1/2013
• Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function  
  Meltzer EO, Kuna P, Nolte H, Nayak AS, LaForce C on behalf of the P04073 Study Investigators, Eur Respir J, 1/1/2012
• Allergic rhinitis substantially impacts patients quality of life: findings from the Nasal Allergy Survey Assessing Limitations  
  Meltzer EO, Gross GN, Katial R, Storms WW, J Fam Pract, 1/1/2012
• Closing thoughts: implications of the findings from the National Allergy Survey Assessing Limitations for the management of allergic rhinitis in America  
  Stoloff SW, Hadley JA, Meltzer EO, J Fam Pract, 1/1/2012
• Asthma burden in the United States: Results of the 2009 Asthma Insight and Management surveyAllergy and Asthma Proceedings  
  Meltzer EO, Blaiss MS, Nathan RA, Doherty DE, Murphy KR, Stoloff SW, Allergy Asthma Proc, 1/1/2012
• Patient and physician asthma deterioration terminology: Results from the 2009 Asthma Insight and Management surveyAllergy and Asthma Proceedings  
  Blaiss MS, Nathan RA, Stoloff SW, Meltzer EO, Murphy KR, Doherty DE, Allergy Asthma Proc, 1/1/2012
• Asthma management and control in the United States: Results of the 2009 Asthma Insight and Management surveyAllergy and Asthma Proceedings  
  Murphy KR, Meltzer EO, Blaiss MS, Nathan RA, Stoloff SW, Doherty DE, Allergy Asthma Proc, 1/1/2012
• Comparison of the Asthma in America and Asthma Insight and Management surveys: Did asthma burden and care improve in the United States between 1998 and 2009? Allergy a...  
  Nathan RA, Meltzer EO, Blaiss MS, Murphy KR, Doherty DE, Stoloff SW, Allergy Asthma Proc, 1/1/2012
• A novel intranasal therapy of azelastine with fluticasone from the treatment of allergic rhinitis  
  Carr W, Bernstein J, Lieberman P, Meltzer EO, Bachert C, Price D, et al, J Allergy Clin Immunol, 1/1/2012
• MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-bl...  
  Meltzer EO, La Force C, Ratner P, Price D, Ginsberg D, Carr W, Allergy and Asthma Proc, 1/1/2012
• Burden of Allergic Rhinitis: Allergies in America, Latin America, and Asia-Pacific Adult Surveys  
  Meltzer, EO, Blaiss MS, Naclerio RM, Stoloff SW, Derebery MJ, Nelson HS, Boyle JM, Wingertzahn MA, Allergy Asthma Proc, 1/1/2012
• Allergic rhinitis and its impact on asthma (ARIA): Achievements in 10 years and future needs  
  Bousquest J, Schunemann HJ, Samolinski B, et al (incl Meltzer EO), J Allergy Clin Immunol, 1/1/2012
• Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis  
  Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C, Allergy Asthma Proc, 1/1/2012
• Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo controlled trial in children 4-9 years old with mild persistent asthma  
  Skoner DP, Meltzer EO, Milgrom H, Strysazk P, Teper A, Staudinger H, J Asthma, 1/1/2011
• Differences in recommendations between the allergic rhinitis and its impact on asthma update 201 and US rhinitis practice parametersLetter to Editor  
  Chipps B, Spector S, Farrar J, Carr W, Meltzer E, Storms W, Kaliner M, Luskin A, Bukstein D, Oppenheimer J, Smart B, Derebery J, Harder J, Dykewicz M, Benninger M, J Allergy Clin Immuunol, 1/1/2011
• The economic impact of allergic rhinitis and current guidelines for treatement  
  Meltzer EO, Bukstein DA, Ann Allergy Asthma Immunol, 1/1/2011
• Suggested updated approaches to patient managementGuest Editorial  
  Katial RK, Meltzer EO, Lieberman P, Ratner PH, Berger WE, Kaliner MA, Siegel CJ, Bukstein DA, Ciervo CA, Marple B, Ann Allergy Asthma Immunol, 1/1/2011
• Two-week comparison study of olopatadine hydrochloride nasal spray 06% versis azelastine hydrochloride nasal spray 01% in patients with vasomotor rhinitis  
  Lieberman P, Meltzer EO, LaForce CF, Darter AL, Tort MJ, Allergy Asthma Proc, 1/1/2011
• Major symptom score utility index for patients with acute rhinosinusitis  
  Revicki DA, Margolis MK, Thompson CL, Meltzer EO, Sandor DW, Shaw JW, Am J Rhinology & Allergy, 1/1/2011
• The role of nasal corticosteroids in the treatment of rhinitis  
  Meltzer EO, Immunol Allergy Clin N Am, 1/1/2011
• Diagnostic strategies in nasal congestion  
  Krouse JH, Lund V, Fokkens W, Meltzer EO, Int J Gen Med, 1/1/2010
• Join now to see all